Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2
1.0.0-ballot - STU Ballot International flag

Potential Drug-Drug Interaction (PDDI) CDS IG : STU1 Ballot 2, published by HL7 Clinical Decision Support Workgroup. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions

ValueSet: valueset-nepafenac-exclude (Experimental)

Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nepafenac-exclude Version: 1.0.0-ballot
Draft as of 2018-07-02 Computable Name: Valueset_nepafenac_exclude

Copyright/Legal: (copyright expectations unknown)

ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.

To refine valueset for Warfarin + NSAID PDDI-CDS


This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include these codes as defined in http://www.nlm.nih.gov/research/umls/rxnorm
    603978nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]
    1365866nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]
    603977nepafenac Ophthalmic Suspension [Nevanac]
    1365864nepafenac Ophthalmic Suspension [Ilevro]
    578044nepafenac 1 MG/ML Ophthalmic Suspension
    1362132nepafenac 3 MG/ML Ophthalmic Suspension
    578043nepafenac Ophthalmic Suspension
    1158407nepafenac Ophthalmic Product
    1365865Ilevro Ophthalmic Product
    1182860Nevanac Ophthalmic Product



Expansion based on codesystem RxNorm version ??rx1

This value set contains 10 concepts.

  603978http://www.nlm.nih.gov/research/umls/rxnormnepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]
  1365866http://www.nlm.nih.gov/research/umls/rxnormnepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]
  603977http://www.nlm.nih.gov/research/umls/rxnormnepafenac Ophthalmic Suspension [Nevanac]
  1365864http://www.nlm.nih.gov/research/umls/rxnormnepafenac Ophthalmic Suspension [Ilevro]
  578044http://www.nlm.nih.gov/research/umls/rxnormnepafenac 1 MG/ML Ophthalmic Suspension
  1362132http://www.nlm.nih.gov/research/umls/rxnormnepafenac 3 MG/ML Ophthalmic Suspension
  578043http://www.nlm.nih.gov/research/umls/rxnormnepafenac Ophthalmic Suspension
  1158407http://www.nlm.nih.gov/research/umls/rxnormnepafenac Ophthalmic Product
  1365865http://www.nlm.nih.gov/research/umls/rxnormIlevro Ophthalmic Product
  1182860http://www.nlm.nih.gov/research/umls/rxnormNevanac Ophthalmic Product

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code